GSK vs KVUE · P/E 13, $103.31B cap vs P/E 21, rev $15.12B
GlaxoSmithKline PLC ADR (GSK) versus Kenvue Inc. (KVUE) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Kenvue Inc. (KVUE) is a household & personal products company listed on NYSE.
GSK does not have a complete income-statement cache yet.
Latest reported KVUE revenue for 2025-12-28 was $15.12B. Net income was $1.47B. Revenue was down 2.1% from 2024-12-29 to 2025-12-28. KVUE currently screens at market cap $34.58B and trailing P/E 21.4.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. KVUE currently screens at market cap $34.58B and trailing P/E 21.4.
Not investment advice. Open the GSK and KVUE stock pages for the full models.
Not investment advice.